Rising Hearing Loss in Africa by 2030: Urgent Measures Needed

By Crystal Lubbe

October 17, 2024

The article from the World Health Organization (WHO) Regional Office for Africa, titled “Burden of hearing loss in Africa could rise to 54 million by 2030: WHO report,” presents a comprehensive analysis of the “burden of hearing loss in Africa” and its future projections.

Current Hearing loss Prevalence and Projections for 2030

Currently, 40 million people in Africa manage hearing loss, and this number will likely grow to 54 million by 2030. Without action, the burden of hearing loss in Africa will rise to 97 million by 2050.

Economic and Social Impact of hearing loss in Africa

The economic and social impact of hearing loss is significant, costing the continent around $27 billion annually. This issue profoundly affects human lives, delaying language development in children, leading to poor educational outcomes, and limiting career prospects. Furthermore, adults face increased risks of isolation, loneliness, depression, and dementia.

Factors Driving the Surge in Hearing Loss

Hearing loss in Africa is exacerbated by several factors, including a severe shortage of ear and hearing care (EHC) specialists, with over 56% of African countries having only one ear, nose, and throat (ENT) specialist per million people, compared to approximately 50 per million in Europe. This workforce is also unevenly distributed, concentrated mainly in urban areas, leaving rural populations underserved. Furthermore, only about 10% of the 33 million Africans in need of hearing aids have access, largely due to high costs and financial barriers.

Preventable Causes

A significant portion of hearing loss is preventable. Up to 75% of hearing loss in children from low- and middle-income countries results from preventable causes such as infections, common ear diseases, and birth complications. Nonetheless, many countries fail to conduct routine hearing screenings for newborns.

Integration and Policy Gaps

EHC services are often not included in priority health programs like school health, occupational health, or healthy aging initiatives. Many nations lack national policies to strengthen EHC delivery, and those with plans often see low implementation levels. Alarmingly, 35% of countries do not provide a budget for EHC activities, shifting the financial burden onto patients.

Recommendations

The report urges several critical actions:

  • Nations must advocate for policies focused on EHC and related activities.
  • Countries should integrate EHC into existing health programs to maximize resource use.
  • Authorities need to pursue public-private partnerships to strengthen EHC services.
  • Governments must allocate dedicated funding to equip facilities, provide essential products and technologies, and boost health workforce capacity and EHC research.

Overall, the report emphasizes the urgent necessity for comprehensive and integrated strategies to tackle the growing burden of hearing loss in Africa effectively.

Reference url

Recent Posts

Trump drug price reform
     

A Systems Dynamics Approach to Lowering Drug Prices by 30–80% in the US

💡 Can the U.S. lower drug prices by 30–80% while improving access and preserving innovation?

President Trump’s recent Executive Order lays the groundwork for bold reforms—targeting international price gaps, PBM markups, and regulatory delays.

This article applies a systems dynamics approach to identify leverage points and feedback loops driving high U.S. drug costs—and outlines concrete, policy-based strategies to reverse them.

Explore how systemic thinking can drive sustainable, scalable change in U.S. pharmaceutical pricing.

#SyenzaNews #DrugPricing #HealthcarePolicy #SystemsThinking #PharmaInnovation

EU Multiannual Financial Framework
     

EFPIA Advocates for Stronger Life Sciences in EU Multiannual Financial Framework

💡 How can the EU strengthen its pharmaceutical sector for the future?

The EFPIA has laid out critical recommendations for the next EU Multiannual Financial Framework (2028-2034), focusing on boosting funding for life sciences research, enhancing regulatory competitiveness, and improving health data infrastructure. These insights could significantly shape the future landscape of healthcare in Europe.

Dive into the full article to learn how these recommendations aim to propel innovation and increase access to medicines across Europe!

#SyenzaNews #pharmaceuticals #healthcarepolicy

NICE health technology evaluations
        

Evolving NICE Health Technology Evaluations: Enhancing Patient Perspectives and Addressing Health Inequalities

🌟 Are you ready to embrace a new era in health technology evaluations?

Our latest article dives into the recent updates from NICE regarding the incorporation of patient perspectives and tackling health inequalities in their health technology assessments. By exploring stakeholder feedback and proposed methodologies, we uncover a shift towards more inclusive and transparent evaluations that could reshape market access and reimbursement policies in the UK healthcare system.

Don’t miss out on these vital insights that could impact your understanding of healthcare value! Read the full article [here](https://www.nice.org.uk/process/pmg36/documents/consultation-comments-and-responses).

#SyenzaNews #HealthEconomics #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.